|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene 显示文摘 | Frosk P Weiler T Nylen E | 2002 | Am J Hum Genet2002，70，3： | 1 |
| 2 | Ubiquitous expression of the calcitonin - i gene in multiple tissues in response to sepsis 显示文摘 | Muller B White JC Nylen ES | 2001 | J Clin Endocrinol Metab2001，86，： | 1 |
| 3 | Procalcitonin assay in sys- temic inflammation, infection, and sepsis: clinical utility and limitations显示文摘 | Becker K L Snider R Nylen E S | 2008 | Crit Care Med2008，36，3： | 1 |
| 4 | Procalcitonin assay in systemic inflammation,infection, and sepsis: clinical utility and limitations 显示文摘 | Becker KL Snider R Nylen ES | 2008 | Crit Care Med2008，36，： | 1 |
| 5 | Procalcitonin and itscomponent peptides in systemic inflammation 显示文摘 | Snide RH Jr Nylen ES Becker KL | 1997 | J InvestigMed1997，45，9： | 1 |
| 6 | Procalcitonin in sepsis and systemic inflammation:a harmful biomarker and a therapeutic target显示文摘 | Becker KL Snider R Nylen ES | 2010 | Br J Pharmacol2010，159，2： | 1 |
| 7 | The structure of α-Zn4Sb3: Ordering of phonon-glass thermoelectric material β-Zn4Sb3显示文摘 | NYLEN J ANDERSSON M LIDIN S HAUSSERMANN U | 2004 | J Am Chem Soc2004，126，16： | 1 |
| 8 | Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis显示文摘 | Nylen ES Whang KT Snider RH Jr | 1998 | Crit Care Med1998，26，6： | 1 |
| 9 | Procalcitonin and its component peptides in systemic inflammation:immunochenmical characteriza- tion显示文摘 | Snider RH Nylen ES Becker KL | 1997 | J Investid Med1997，45，： | 1 |
| 10 | Procalcitonin assay insy stemic inflammation, infection and sepsis: Clinical utility and Limitations 显示文摘 | Becker K L Snider R Nylen E S | 2008 | Crit Care Med2008，36，3： | 1 |
| 11 | Low thermal conductivity coatings for gas turbine applications 显示文摘 | Markocsan N Nylen P Wigren J | 2007 | Thermal Spray Technology2007，16，4： | 1 |
| 12 | Preparation of catalysts from microemulsions and their applications in heterogeous catalysis显示文摘 | Eriksson S Nylen U Rojas S | 2004 | Appl Catal A2004，265，： | 1 |
| 13 | Inverse eigenvalue problem:existence of special sprignt-mass systems显示文摘 | Frank Uhlig | 1997 | Inverse problem1997，，13： | 1 |
| 14 | Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury显示文摘 | Nylen K Ost M Csajbok LZ el al | 2008 | Acta Neurochir (Wien)2008，150，： | 1 |
| 15 | The future diagnostic role of procalcitonin levels: the need for improved sensitivity显示文摘 | Nylen E Muller B Becker K | 2003 | Clin In- fect Dis2003，36，6： | 1 |
| 16 | In Vitro and in Vivo Caleitonin Ⅰ Gene Expression in Parenehymal Cells, A Novel Product of Human Adipose Tissue显示文摘 | Linscheid P Seboek D Nylen E S | 2003 | Endocrinology2003，144，12： | 1 |
| 17 | Clinical review 167: Pro- ealeitonin and the ealeition gene of peptides in inflammation, infec- tion, and sepsis; a journey from caleitonin back to its precursors 显示文摘 | Beeker KL Nylen ES White JC | 2004 | J Clin Endoerionl Metab2004，89，4： | 1 |
| 18 | Procalcitonin assay in systemic inflammation,infection,and sepsis:clinical utility and limitations显示文摘 | Becker KL Snider R Nylen ES | | 0，，03： | 1 |
| 19 | Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations显示文摘 | Becker KL Snider R Nylen ES | 2008 | Crit Care Med2008，36，3： | 1 |
| 20 | Procalcitonin sepsis andsystem micinflam ation: aharmful biomarker and therapeutictarget显示文摘 | Beckerkl KL Snider R Nylen ES | 2010 | Br J Pharmacol2010，159，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员